Vertex Pharma ( VRTX) downgraded at Wachovia from Market Perform to Underperform. Regulatory risks could weigh on the stock in the coming quarters. YRC Worldwide ( YRCW) downgraded at Wachovia to Underperform. Stock will struggle to find a bottom unless fundamentals improve in the near term. Stock will likely trade down around $10 to $13.